GlassScriptPhysician profile
Brett J King
NPI 1669541231
$2,022.51
in general payments reported to CMS, 2019-2025
13 companies · $400 in 2025
The $400 reported for 2025 was more than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $678 · 2020: $359 · 2021: $115 · 2022: $100 · 2023: $247 · 2024: $123 · 2025: $400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $770.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $770.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $398.50 | 2019-2020 | |
| Nobel Biocare USA | $354.22 | 2019-2021 | |
| Kls-Martin L.P. | $259.19 | 2019-2025 | |
| Stryker Corporation | $151.35 | 2019-2021 | |
| Revance Therapeutics, INC. | $138.78 | 2025 | Daxi |
| Acera Surgical, INC. | $132.09 | 2025 | Restrata Wound Matrix |
| Baxter Healthcare | $124.16 | 2023 | Artiss |
| Abbvie INC. | $122.57 | 2023 | |
| Terumo Bct, INC. | $105.65 | 2019 | |
| Sientra, INC. | $100.00 | 2022 | |
| Organogenesis INC. | $95.24 | 2025 | Puraply Wound Matrix |
| Biohorizons Implant Systems INC. | $25.04 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $15.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.